ENPP2 and Hepatic fibrosis: In comparisons of clinical markers between CNALT and non‐CNALT groups, non‐CNALT patients had significantly lower scores for PLT (P = 0.030) and albumin (P = 0.046) but higher scores for liver fibrosis markers (P < 0.05, each) except autotaxin.